Ian Shakil - Apr 1, 2024 Form 4 Insider Report for Augmedix, Inc. (AUGX)

Role
CHIEF STRATEGY OFFICER, Director
Signature
/s/ Todd Holvick, Attorney-in-Fact
Stock symbol
AUGX
Transactions as of
Apr 1, 2024
Transactions value $
-$347,247
Form type
4
Date filed
4/3/2024, 09:30 PM
Previous filing
Apr 1, 2024
Next filing
Apr 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUGX Common Stock Options Exercise $32.9K +51.3K +27.36% $0.64* 239K Apr 1, 2024 Direct F1
transaction AUGX Common Stock Sale -$200K -51.3K -21.48% $3.89 188K Apr 1, 2024 Direct F1, F2
transaction AUGX Common Stock Sale -$30.7K -7.63K -4.07% $4.02 180K Apr 1, 2024 Direct F1, F3
transaction AUGX Common Stock Sale -$150K -38.5K -21.36% $3.89 142K Apr 2, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUGX Stock Option (Right to Buy) Options Exercise $0 -51.3K -54.47% $0.00 42.9K Apr 1, 2024 Common Stock 51.3K $0.64 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan.
F2 This transaction was executed in multiple trades ranging from $3.8000 to $3.9900. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3 This transaction was executed in multiple trades ranging from $3.9900 to $4.1100. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F4 Fully vested.